WHO

We provide our customers in the research and development (R&D) field with access to the World Health Organization (WHO) Model List of Essential Medicines. This list serves as a valuable resource, guiding healthcare systems in prioritizing access to safe, effective, and affordable medications across diverse therapeutic categories. By leveraging this comprehensive list, our customers can make informed decisions regarding resource allocation, procurement strategies, and the development of essential medicine lists tailored to their specific needs and contexts. This initiative underscores our commitment to supporting global health initiatives and advancing research efforts in the pharmaceutical and healthcare sectors.